Intracranial compliance in patients with COVID-19: a multicenter observational study

Author(s):Show less -

Silveira, Ana Flavia ; Santos, Marcella Barreto ; Collange, Nelci Zanon ; Hayashi, Cintya Yukie ; Vilela, Gustavo Henrique Frigieri ; de Almeida, Samantha Longhi Simoes ; de Andrade, Joao Brainer Clares ; Rojas, Salomon ; de Moraes, Fabiano Moulin ; Veiga, Viviane Cordeiro ; Flato, Uri Adrian Prync ; Russo, Thiago Luiz ; Silva, Gisele Sampaio

• Document type: Journal article
• Source: Arquivos de Neuro-Psiquiatria; v. 82, n. 09, p. 8-pg., 2024-09-01.

Abstract

Background Patients with severe coronavirus disease-19 (COVID-19) may require the use of invasive mechanical ventilation (MV) for prolonged periods. Aggressive MV parameters have been associated with changes in intracranial pressure (ICP) in patients with acute intracranial disorders. Significant ICP elevation could compromise intracranial compliance (ICC) and cerebrovascular hemodynamics (CVH). However, the effects of these parameters in individuals without neurological disorders have not yet been evaluated. Objective To evaluate ICC in patients on MV with COVID-19 infection compared to other diagnoses, to better characterize the effects of MV and COVID-19 upon ICC. We also compared between the ICC in patients with COVID-19 who did not require MV and healthy volunteers, to assess the isolated effect of COVID-19 upon ICC. Methods This was an exploratory, observational study with a convenience sample. The ICC was evaluated with a noninvasive ICP monitoring device. The P2/P1 ratio was calculated by dividing the amplitude of these two points, being defined as "abnormal" when P2 > P1. The statistical analysis was performed using a mixed linear model with random effects to compare the P2/P1 ratio in all four groups on the first monitoring day. Results A convenience sample of 78 subjects (15 MV-COVID-19, 15 MV non-COVID-19, 24 non-MV-COVID-19, and 24 healthy participants) was prospectively enrolled. There was no difference in P2/P1 ratios between MV patients with and without COVID-19, nor between non-MV patients with COVID-19 and healthy volunteers. However, the P2/P1 ratio was higher in COVID-19 patients with MV use than in those without it. Conclusion This exploratory analysis suggests that COVID-19 does not impair ICC. (AU)

• FAPESP's process: 23/00506-3 - MODERADE TO VIGOROUS INTENSITY MULTIMODAL CIRCUIT TRAINING EFFICACY TO INCREASE STEPS PER DAY IN STROKE SURVIVORS: RANDOMIZED CLINICAL TRIAL.
• Grantee: Ana Flávia Silveira
• Support Opportunities: Scholarships in Brazil - Doctorate